MedPath

Group Therapy and Aury - Blended Care Intervention Study

Phase 2
Registration Number
DRKS00033550
Lead Sponsor
Humboldt-Universität zu Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
120
Inclusion Criteria

Ability to consent
-German-speaking
-Primary diagnosis of one of the above-mentioned disorders (unipolar depression, anxiety disorder, obsessive-compulsive disorder, adjustment disorder, non-organic insomnia)

Exclusion Criteria

- Psychopathology: Indication for inpatient treatment (acute psychosis, suspected danger to self or others, substance dependence
self-harm or danger to others, substance dependence (F1X.2), serious psychopathology), clinical impression of inadequately treated borderline personality disorder, pronounced personality disorders which, according to clinical impression limits group ability
- No willingness to participate in group therapy
- No willingness to use the digital chatbot
- No willingness to participate in the study in case of randomized allocation to the waiting control group
- Start of guideline psychotherapy (excluding probationary sessions) in the intervention period

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath